SCHEMBL6011189

SCHEMBL6011189

Nc1ccc(-c2ccccc2O)c(N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 3/20 0.47
SMARCA2 P51531 3/20 0.47
SMARCA4 P51532 3/20 0.47
PBRM1 Q86U86 3/20 0.47
BRD4 O60885 1/20 0.47
SMN1; SMN2 Q16637 6/20 0.45
ALDH1A1 P00352 5/20 0.45
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
TDP1 Q9NUW8 3/20 0.45
TSHR P16473 2/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPK1 P28482 1/20 0.45
ALOX15 P16050 2/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
HPGD P15428 3/20 0.44
LMNA P02545 3/20 0.44
MEN1 O00255 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5687750 0.89 SMN1; SMN2 (0.50) NR1I2SMARCA2SMARCA4PBRM1BRD4
SCHEMBL5685322 0.87 CASP1 (0.50) SMN1; SMN2ALDH1A1NPC1RAB9ATDP1
SCHEMBL3791666 0.85 ALDH1A1 (0.56) NR1I2SMARCA2SMARCA4PBRM1BRD4
SCHEMBL28448815 0.84 ALDH1A1 (0.58) SMN1; SMN2ALDH1A1NPC1RAB9ATDP1
SCHEMBL6011670 0.84 PLAU (0.44) NR1I2SMARCA2SMARCA4PBRM1BRD4
SCHEMBL6011515 0.84 PLAU (0.44) NR1I2SMARCA2SMARCA4PBRM1BRD4
SCHEMBL6573277 0.83 SMN1; SMN2 (0.45) NR1I2SMARCA2SMARCA4PBRM1BRD4
SCHEMBL6011315 0.83 PDE10A (0.52) SMN1; SMN2ALDH1A1NPC1RAB9ATDP1
SCHEMBL6573481 0.83 PDE10A (0.52) NR1I2SMARCA2SMARCA4PBRM1BRD4
SCHEMBL6011318 0.82 ALDH1A1 (0.65) SMN1; SMN2ALDH1A1NPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355619-B1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES WELLA AG (DE) 2006-12-06 EP claimed
EP-1355619-B1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES WELLA AG (DE) 2006-12-06 EP disclosed
US-7056347-B2 Coloring agents for keratin fibers containing (1,1′-biphenyl)-2,4-diamine derivatives in addition to novel (1,1′-biphenyl)-2,4-diamine-derivatives WELLA AG (DE) 2006-06-06 US disclosed
EP-1355619-A1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES Wella Aktiengesellschaft (DE) 2003-10-29 EP disclosed
US-20030172470-A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2003-09-18 US disclosed
WO-2002062307-A1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2002-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030172470-A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives KRT18, DSP, DSG1 NR1I2 1982/4885SMARCA2 650/4885SMARCA4 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.